Early and late mortality after myocardial infarction in men and women: Prospective observational study

Heart

Volumn 91, Issue 3, 2005, Pages 305-307

  Griffith, D ^a   Hamilton, K ^a   Norrie, J ^b   Isles, Christopher G ^a  

^a DUMFRIES AND GALLOWAY ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGE; AGED; ANAMNESIS; ARTICLE; BLOOD CLOT LYSIS; CLINICAL FEATURE; COMORBIDITY; CONFIDENCE INTERVAL; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; SEX RATIO; SMOKING; SOCIAL ISOLATION; UNITED KINGDOM; VASCULAR DISEASE; EPIDEMIOLOGY; FIBRINOLYTIC THERAPY; METHODOLOGY; TIME;

AGE FACTORS; AGED; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; SCOTLAND; SEX DISTRIBUTION; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 14244255896     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.033035     Document Type: Article

References (15)

1. Mahon NG, McKenna CJ, Codd MB, et al. Gender difference in the management and outcome of acute myocardial infarction in unselected patients in the thrombolytic era. Am J Cardiol 2000;85:921-6.
2. Gan SC, Beaver SK, Houck PM, et al. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med 2000;343:8-15.
3. Vaccarino V, Krumholz HM, Yarzebski J, et al. Sex differences in 2-years mortality after hospital discharge for myocardial infarction. Ann Intern Med 2001;134:173-81.
4. de Gevigney G, Mosnier S, Ecochard R, for the PRIMA group, et al. Are women with acute myocardial infarction managed as well as men? Does it have consequences on in-hospital mortality? Analysis of an unselected cohort of 801 women and 1,718 men. Acta Cardiol 2001;56:169-79.
5. Heer T, Shiele R, Schneider S, et al. Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). Am J Cardiol 2002;89:511-7.
6. Hanratty B, Lawlor DA, Robinson MB, et al. Sex differences in risk factors, treatment and mortality after acute myocardial infarction: an observational study. J Epidemiol Commun Health 2000;54:912-5.
7. Lundberg V, Wikstrom B, Bostrom S, et al. Exploring sex differences in case fatality in acute myocardial infarction or coronary death events in the northern Sweden MONICA project. J Intern Med 2002;251:235-44.
8. Kaplan KL, Fitzpatrick P, Cox C, et al. Use of thrombolytic therapy for acute myocardial infarction: effects of gender and age on treatment rates. J Thromb Thrombolysis 2002;13:21-6.
9. Daly J, Sindore AP, Thompson DR, et al. Barriers to participation in and adherence to cardiac rehabilitation programs: a critical literature review. Prog Cardiovasc Nurse 2002;17:8-17.
10. Bannerman A, Hamilton K, Isles C, et al. Myocardial infarction in men and women under 65 years of age: no evidence of gender bias. Scot Med J 2001;46:73-8.
11. McMeeken K, Mark J, McGoey P, et al. Uptake of cardiac rehabilitation is under estimated by failure to include in patient rehabilitation and contribution of the heart manual [abstract]. Eur J Cardiovasc Prevention Rehab 2004;11(suppl 1):P-148.
12. Tunstall-Pedoe H, Morrison C, Woodward M, et al. Sex difference in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985-91: presentation, diagnosis, treatment and 28 day case fatality or 3991 events in men and women. Circulation 1996;93:1981-92.
13. MacIntyre K, Stewart S, Capewell S, et al. Gender and survival: a population based study of 201,114 men and women following a first acute myocardial infarction. J Am Coll Cardiol 2001;38:729-35.
14. Montaye M, De Bacquer D, De Backer G, et al on behalf of the EURO-ASPIRE Investigators. Overweight and obesity: a major challenge for coronary heart disease secondary prevention in clinical practice in Europe. Eur Heart J 2000;21:808-13.
15. Anon. EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in 9 countries. Lancet 2001;357:995-1001.